Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate

The combination effect of adriamycin (ADM) and medroxyprogesterone acetate (MPA) was examined in vitro against human breast carcinoma MCF‐7 and its ADM‐resistant line (MCF‐7/ADM). MCF‐7 cells, which are positive for estrogen receptors, progesterone receptors and high‐affinity MPA‐binding activity, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Hiroyuki, Okabe, Masami, Gomi, Katsushige, Horiuchi, Ryuya, Mikami, Koji, Naito, Mikihiko, Tsuruo, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1994
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919497/
https://www.ncbi.nlm.nih.gov/pubmed/8014112
http://dx.doi.org/10.1111/j.1349-7006.1994.tb02393.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919497/
https://www.ncbi.nlm.nih.gov/pubmed/8014112
http://dx.doi.org/10.1111/j.1349-7006.1994.tb02393.x

Ejemplares similares